Issue 4/2018
Special Issue on Pharmacovigilance
Content (29 Articles)
Overview of this issue: pharmacovigilance, what is new?
Linda Gore Martin, Yolande Hanssens, Vibhu Paudyal
The role and strategy of ISoP in global pharmacovigilance
Sten Olsson, Mira Harrison-Woolrych
An historical overview over Pharmacovigilance
Giulia Fornasier, Sara Francescon, Roberto Leone, Paolo Baldo
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Paolo Baldo, Sara Francescon, Giulia Fornasier
Current trends in pharmacovigilance: value and gaps of patient reporting
Pedro Inácio, Afonso Cavaco, Marja Airaksinen
Pharmacovigilance in developing countries (part I): importance and challenges
Shaimaa Elshafie, Iman Zaghloul, Anne Marie Roberti
Pharmacovigilance in developing countries (part II): a path forward
Shaimaa Elshafie, Anne Marie Roberti, Iman Zaghloul
Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar
Moza Al Hail, Wessam Elkassem, Anas Hamad, Pallivalappila Abdulrouf, Binny Thomas, Derek Stewart
The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions—why this is not a small problem
Carolyn Vera Coulter
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
Sara Francescon, Giulia Fornasier, Paolo Baldo
Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance
Angela Lupattelli, Olav Spigset, Hedvig Nordeng
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension
Marie-Camille Chaumais, Caroline O’Connell, Laurent Savale, Christophe Guignabert, Frédéric Perros, Xavier Jaïs, Olivier Sitbon, Marc Humbert, David Montani
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
G. Fornasier, M. Taborelli, S. Francescon, J. Polesel, M. Aliberti, P. De Paoli, P. Baldo
Finasteride use during pregnancy and early neonatal outcome: a case report
Doua AlSaad, Ben H. Lee, Sawsan Al-Obaidly
Potential negative impact of informing patients about medication side effects: a systematic review
Jimmy Jose, Lamia AlHajri
Pharmacovigilance in China: development and challenges
Ying Zhao, Tiansheng Wang, Guangyao Li, Shusen Sun
Pharmacovigilance in oncology
Paolo Baldo, Giulia Fornasier, Laura Ciolfi, Ivana Sartor, Sara Francescon
Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals
Anna Laven, Katharina Schmitz, Wilhelm-Hubertus Franzen
Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
João P. Aguiar, Fábio Cardoso Borges, Rodrigo Murteira, Catarina Ramos, Emanuel Gouveia, Maria José Passos, Ana Miranda, Filipa Alves da Costa
Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database
Ying Zhao, Haidong Lu, Sydney Thai, Xiaotong Li, John Hui, Huilin Tang, Suodi Zhai, Lulu Sun, Tiansheng Wang
Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population
Sara Modig, Sölve Elmståhl
Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
Raymond Li, Colin Curtain, Luke Bereznicki, Syed Tabish Razi Zaidi
Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy
Geoffrey C. Wall, Matthew J. Taylor, Hayden L. Smith
Healthcare professionals’ knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia
Mohammed Assen Seid, Asmamaw Emagn Kasahun, Bamlak Markos Mante, Saron Naji Gebremariam
Comparison of different methods for causality assessment of adverse drug reactions
Sapan Kumar Behera, Saibal Das, Alphienes Stanley Xavier, Srinivas Velupula, Selvarajan Sandhiya
Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone
Jun-Hong Ye, Yunn-Fang Ho, Angela W.-F. On, Wen-Wen Chen, Yen-Ming Huang, Wei-I. Huang, Yun-Wen Tang
Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database
Xiaotong Li, Sydney Thai, Wenchao Lu, Shusen Sun, Huilin Tang, Suodi Zhai, Tiansheng Wang
Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study
Luis Hermenegildo Martin Arias, Antonio Martin Gonzalez, Rosario Sanz Fadrique, Esther Salgueiro, Maria Sainz